Astragalus Root Extract Market to Reach USD 566.6 Mn by 2035, Driven by Standardized Therapeutic Formulations
The global astragalus root extract market, valued at USD 386.5 million
in 2025, is forecast to grow to USD 566.6 million by 2035, at a CAGR of 3.9%,
according to recent industry projections. The market is set to add an absolute
dollar opportunity of USD 180.1 million over the forecast period, driven by the
rising demand for immune-boosting nutraceuticals, broader integration of
traditional medicinal ingredients, and rapid validation of clinical benefits in
pharmaceutical-grade products.
With astragalus gaining prominence as a standardized herbal
ingredient, its growing acceptance across dietary supplements, functional food,
and pharmaceutical formulations reflects a structural shift toward proven
natural wellness solutions. The market is projected to reach USD 472.4 million
by 2030, registering an incremental addition of USD 85.9 million in the first
half of the decade, followed by a moderately back-loaded growth path.
To Explore Detailed Market Data, Segment-Wise Forecasts,
and Competitive Insights, Request Sample Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-4736
Adaptogenic Demand and TCM Modernization Fuel Market
Growth
The market’s progress is closely linked to rising global
acceptance of immune-modulating herbs, particularly those backed by Traditional
Chinese Medicine (TCM) principles. Astragalus, rich in polysaccharides and
astragaloside IV, continues to gain regulatory support due to its validated role
in cardiovascular health, stress adaptation, and immune system resilience.
Standardized extraction processes are accelerating
pharmaceutical adoption, especially as manufacturers deploy potency-specific
formulations for chronic inflammation management. These advances are
positioning astragalus as a credible alternative to synthetic immune
modulators, expanding its reach across clinical and consumer markets.
Powder Segment Dominates with 44% Share
In 2025, powdered astragalus root extract accounts for 44% of
total market share, underpinned by cost efficiency and versatility in mass
supplement production. Its stable shelf life, compatibility with capsules and
tablets, and dosing precision make it the preferred choice for nutraceutical
manufacturers.
- Widely
used in pharmaceutical formulations due to potency standardization
- Increasing
availability of certified organic, third-party tested variants
- Strong
compliance with GMP manufacturing and global quality benchmarks
This format is expected to remain dominant, supported by
tightening potency verification norms and international regulatory scrutiny.
Food & Beverage Applications Lead with 47% Share
Functional health products infused with botanicals are
transforming consumer wellness trends worldwide. Astragalus extract holds 47%
share in food & beverage applications, with demand accelerating across
herbal teas, fortifying beverages, gummies, and dietary blends.
Consumer awareness of stress-linked disorders, obesity, and
metabolic diseases is propelling herbal consumption beyond supplements.
Adoption is significantly higher in Asia-Pacific and North America, where
retail innovation and clean-label preferences shape product portfolios.
Top Growth Countries: China Leads with 6.2% CAGR
China dominates production with 156 GMP-certified
facilities, generating 4.2 million kg of standardized extract in 2024, 60% of
which targets global nutraceutical markets. India follows with strong Ayurvedic
integration and a 28% YoY surge in standardized extract exports.
Germany is emerging as a pharmaceutical-grade import hub,
while France’s phytotherapy ecosystem and the UK’s vegan clean-label segment
support consistent demand growth.
Competitive Landscape: Standardized Technology Sets the
Tone
The market remains moderately fragmented, yet competitive
differentiation is shifting toward clinical validation and standardized
extraction. Key leaders include:
- Nutragreen
Biotechnology Co. and Xi’An Sanwei Biotechnology Co. – focus on
GMP-certified export supplies
- Mountain
Rose Herbs & Z Natural Foods LLC – strong organic, retail-driven
positioning
- Martin
Bauer Group & Naturex – pharmaceutical-grade standardization and
research-led value creation
Regional players such as VidyaHerbs and Vita Forte Inc.
capitalize on localized demand through cost leadership and quick turnaround
sourcing for nutraceutical brands.
Key Companies Profiled are Nutragreen
Biotechnology Co., Xi’An Sanwei Biotechnology Co., Mountain Rose Herbs, Z
Natural Foods LLC, Martin Bauer Group, Naturex, Diana Group, Health Genesis,
Vita Forte Inc., and VidyaHerbs
Information Source: https://www.futuremarketinsights.com/reports/astragalus-root-extract-market
Comments
Post a Comment